DNA Script has announced a distribution agreement with Imperial Life Sciences (ILS) to expand access to the company’s DNA synthesis platform. The partnership will mean DNA Script’s SYNTAX platform will now be available in India. Under the agreement, ILS will distribute DNA Script’s SYNTAX platform throughout the country,… Read More
Diana Turner takes a look at drug discovery in India, a country making the shift from scale to innovation. While the Indian pharmaceuticals sector has long held a key global position… Read More
A chemistry synthesis laboratory entirely operated and led by women scientists has opened in India. ChemiSHE, launched by CRDMO Aragen, was inaugurated on 8 April at Aragen’s Mallapur campus in Hyderabad. Aragen says ChemiSHE is part of a broader strategic initiative to strengthen gender diversity across the company’s scientific workforce and create structured… Read More
An expanded commercial peptide facility in India will open to support emerging biotech programmes. CDMO Neuland Laboratories will open its new commercial peptide facility in the summer of 2026 at its 17-acre Bonthapally manufacturing campus, with further capacity expansions planned as client demand increases. The first of four… Read More
In the In Conversation With series, a part of the free DDW podcast, DDW speaks with members of the drug discovery industry about their work and how it helps turn science into business. In this episode, Bruno Quinney talks to Dr Mrinal Kammili, Head… Read More
Srivats Rajagopal explores the growth of the antibody-body conjugate (ADC) market, development trends and why innovators are turning towards India. The ADC field has reached an inflection point. In 2022, Enhertu, Kadcyla, and Trodelvy together accounted for more than $4 billion of the $4.7 billion in global ADC revenues, and… Read More
Syngene International has announced new investment in peptide laboratory and advanced automation to accelerate drug discovery and development in India. The investments include a dedicated peptide laboratory in Bengaluru and the integration of automation across Drug Metabolism and Pharmacokinetics (DMPK) and Direct-to-Biology (D2B) workflows in Hyderabad. The… Read More
This is the latest episode of the free DDW narrated podcast, titled “Where are scientists making waves in drug discovery?”, which covers three articles written for DDW Volume 24 – Issue 3, Summer 2023. They are called: “How pharma is targeting advances in Alzheimer’s treatments”, “The start-up disrupting… Read More
With elections this year in the US, the UK and India – all major players in the life sciences industry – Ivor Campbell, Chief Executive, Snedden Campbell, asks what changes and benefits we can expect to see for companies and their investors, healthcare providers and patients. Read More
Listen to this article on the DDW Podcast: DDW’s Megan Thomas takes a deeper look into why India is ramping up drug discovery research, and explores the country’s innovation hubs of interest. In the global pharmaceuticals market, India ranks third worldwide for production… Read More
Could India become an important centre of drug discovery innovation? Diana Spencer explores the evolution of the Hyderabad life sciences hub. India is traditionally known as ‘the pharmacy of the world’ due to its huge pharmaceuticals manufacturing capacity and high quantity of exports, particularly generic medicines… Read More
